International Course on Immunology Mexico 2024

Course objective!

Our course will show you how modern immunology can drive the development of innovative treatments!
We will explore exciting advances such as antibody-drug therapy and immunomodulators, and their application in fields such as oncology, infectious diseases and autoimmunity.

We want to bring together students and mentors to foster the professional growth of Latin American immunologists!

Deadline to apply: November 17, 2023

CANDIDATE SELECTION

This 5-day course is open to graduate students, medical students, fellows and early career academics in translational immunology. We target 40-50 students, mostly from Mexico, Latin America and the Caribbean.

  • Applicants will be asked to provide a letter of motivation, a brief CV, a letter of support from their supervisor, and an abstract to be submitted.
  • Supervisor, and an abstract to be presented as a poster.
  • Selected students will receive partial or full funding to cover registration, accommodation and travel expenses.
  • Candidates are encouraged to apply for other sources of funding, as the budget is limited.
  • Selected candidates will be notified by 18, 2023.
  • All selected participants will be required to complete an online pre-course on the Immunopaedia website beginning the week of February 19, 2024.

LOCAL ORGANIZERS

Jose Carlos Crispin: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México.

Yvonne Rosenstein: Instituto de Biotecnología, Universidad
Nacional Autónoma de México, México.

Rosana Pelayo: Instituto Mexicano del Seguro Social (IMSS), México.

INTERNATIONAL ORGANIZERS

Dieter Kabelitz: University of Kiel, Germany.

Michelle Letarte: University of Toronto, Canada.

Clive Gray: Stellenbosch University, South Africa.

MAIN TOPICS

Renowned scientists, both local and international, will teach this course.

 

  • Modulation of peripheral tolerance.
  • Metabolic adaptation to the pathogenic environment.
  • Depletion.
  • Suppression in the context of disease.
  • Redirection of cytotoxicity.
  • Reactivation of immunity.
  • Innovative therapeutic strategies.

Contáctanos

+52 55 2745 9602

contacto@sociedadmexicanadeinmunologia.org